Therapeutic Targeting of Integrin αvβ6 in Breast Cancer-Reference-Cited by-同舟云学术

Therapeutic Targeting of Integrin αvβ6 in Breast Cancer

Published:2014-06-28 Issue:8 Volume:106 Page:
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Moore Kate M.,Thomas Gareth J.,Duffy Stephen W.,Warwick Jane,Gabe Rhian,Chou Patrick,Ellis Ian O.,Green Andrew R.,Haider Syed,Brouilette Kellie,Saha Antonio,Vallath Sabari,Bowen Rebecca,Chelala Claude,Eccles Diana,Tapper William J.,Thompson Alastair M.,Quinlan Phillip,Jordan Lee,Gillett Cheryl,Brentnall Adam,Violette Shelia,Weinreb Paul H.,Kendrew Jane,Barry Simon T.,Hart Ian R.,Jones J. Louise,Marshall John F.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/106/8/dju169/17313640/dju169.pdf

Reference34 articles.

1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

2. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

3. Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer;Wong;Int J Breast Cancer,2012

4. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer;Piccart-Gebhart;N Engl J Med,2005

5. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer;Romond;N Engl J Med,2005

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanical network motifs as targets for mechanomedicine;Drug Discovery Today;2024-10

2. ERK3/MAPK6 promotes triple-negative breast cancer progression through collective migration and EMT plasticity;2024-06-25

3. Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer;npj Precision Oncology;2024-06-05

4. Integrating integrins with the hallmarks of cancer;Matrix Biology;2024-06

5. Bispecific T cell engager-armed T cells targeting integrin ανβ6 exhibit enhanced T cell redirection and antitumor activity in cholangiocarcinoma;Biomedicine & Pharmacotherapy;2024-06